Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 166Polycystic Ovary Syndrome 23Neoplasm Metastasis 10Osteoporosis 7Neoplasms 6Infertility 6Endometrial Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Ovarian Neoplasms 4Breast Carcinoma In Situ 4Arthralgia 4Recurrence 3Hereditary Sensory and Autonomic Neuropathies 3Carcinoma, Ductal, Breast 3Breast Neoplasms, Male 3Breast Cancer Metastatic 3Advanced Breast Cancer 3Triple Negative Breast Neoplasms 2Pain 2Leiomyoma 2Fallopian Tube Neoplasms 2Estrogen Receptor-positive Breast Cancer 2Carcinoma, Lobular 2Bone Diseases, Metabolic 2Uterine Neoplasms 1Patient Acceptance of Health Care 1Ovarian Cysts 1Osteitis Deformans 1Obesity 1Neoplastic Cells, Circulating 1

Interventions

Doxorubicin 13Gemcitabine 10Ifosfamide 9Trabectedin 7Radiotherapy 7Docetaxel 5Dacarbazine 5pazopanib 3Sunitinib 3Sorafenib 3Nivolumab 3Filgrastim 3pembrolizumab 2pegfilgrastim 2liposomal doxorubicin 2eribulin 2cixutumumab 2belinostat 2Radiotherapy, Conformal 2Imatinib Mesylate 2Chemotherapy, Adjuvant 2Bevacizumab 2tremelimumab 1temsirolimus 1soblidotin 1selinexor 1sargramostim 1saracatinib 1rubitecan 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leiomyosarcoma × Letrozole × Clear all
NCT00856050 2017-04-18

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma

Dana-Farber Cancer Institute

Phase 2 Completed
27 enrolled 4 charts
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡